SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OncoGenex Pharmaceuticals Inc. Announces Initiation of Randomized Phase 2 "PACIFIC" Study of OGX-427 in Combination With Zytiga® in Men With Metastatic Castrate-Resistant Prostate Cancer